TMCnet News
Investors look to Lighten Up on Shares of Neuralstem, Shares Down 12.8% (CUR)Dec 04, 2012 (SmarTrend(R) Spotlight via COMTEX) -- Neuralstem (AMEX:CUR) is one of today's worst performing low-priced stocks, down 12.8% to $1.30 on 3.5x average daily volume. Thus far today, Neuralstem has traded 4.5 million shares, vs. average volume of 1.3 million shares per day. The stock has underperformed the Dow (-12.8% to the Dow's -0.1%) and underperformed the S&P 500 (-12.8% to the S&P's -0.2%) during today's trading. Neuralstem Inc. is a biotherapeutics company utilizing its Human Neural Stem Cell technology to develop cures for diseases of the CNS (central nervous system). In the past 52 weeks, shares of Neuralstem have traded between a low of $0.42 and a high of $1.96 and are now at $1.30, which is 210% above that low price. The 200-day and 50-day moving averages have moved 0.21% higher and 0.23% lower over the past week, respectively. Neuralstem (AMEX:CUR) is currently priced 80.8% above its average consensus analyst price target of $0.25. Neuralstem shares have support at the 50-day moving average (MA) of $1.12 and additional support at the 200-day MA of $0.99. SmarTrend is monitoring the recent change of momentum in Neuralstem. Please refer to our Company Overview for the results of our proprietary technical indicators that have been scanning shares of Neuralstem in search of a potential trend change. Write to Chip Brian at [email protected] --------------------------------------------------------------------------------------------- SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.MySmarTrend.com Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.MySmarTrend.com/signup |